225 related articles for article (PubMed ID: 32274730)
1. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
2. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
[TBL] [Abstract][Full Text] [Related]
4. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
5. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
[TBL] [Abstract][Full Text] [Related]
6. Fasting mimicking diet in diabetic mice partially preserves glomerular endothelial glycocalyx coverage, without changing the diabetic metabolic environment.
van der Velden AIM; Koudijs A; Kooijman S; Rietjens RGJ; Sol WMPJ; Avramut MC; Wang G; Rensen PCN; Rabelink TJ; van der Vlag J; van den Berg BM
Am J Physiol Renal Physiol; 2024 May; 326(5):F681-F693. PubMed ID: 38205540
[TBL] [Abstract][Full Text] [Related]
7. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
8. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
9. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
10. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
13. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
14. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
17. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.
Kuwabara A; Satoh M; Tomita N; Sasaki T; Kashihara N
Diabetologia; 2010 Sep; 53(9):2056-65. PubMed ID: 20526760
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
19. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.
Takashima Y; Keino-Masu K; Yashiro H; Hara S; Suzuki T; van Kuppevelt TH; Masu M; Nagata M
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F395-408. PubMed ID: 26764203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
